Optimizing outcomes for octogenarians with invasive bladder cancer: One size does not fit all

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 1, 2013, Pages 1-4

  Resnick, Matthew J ^a   Chang, Sam S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CLINICAL DECISION MAKING; COMORBIDITY; CYSTECTOMY; GERIATRIC CARE; GOLD STANDARD; HEART DISEASE; HOSPITAL READMISSION; HUMAN; LYMPH NODE DISSECTION; MORTALITY; MUSCLE INVASIVE BLADDER CANCER; NOMOGRAM; OCTOGENARIAN; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RISK BENEFIT ANALYSIS; SOCIAL SUPPORT; URINARY DIVERSION;

AGED; DISEASE MANAGEMENT; HUMANS; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84873896177     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.12.024     Document Type: Article

References (25)

1. Huang G.J., Stein J.P. Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer. Curr Opin Urol 2007, 17:369-375.
2. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003, 349:859-866.
3. von der Maase H., Sengeløv L., Roberts J.T., et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 2005, 23:4602-4608.
4. Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005, 48:202-205. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration, Discussion 205-6.
5. Shariat S.F., Milowsky M., Droller M.J. Bladder cancer in the elderly. Urol Oncol 2009, 27:653-667.
6. Prout G.R., Wesley M.N., Yancik R., et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 2005, 104:1638-1647.
7. Konety B.R., Joslyn S.A. Factors influencing aggressive therapy for bladder cancer: An analysis of data from the SEER program. JURO 2003, 170:1765-1771.
8. Schrag D., Mitra N., Xu F., et al. Cystectomy for muscle-invasive bladder cancer: Patterns and outcomes of care in the Medicare population. Urology 2005, 65:1118-1125.
9. Hollenbeck B.K., Miller D.C., Taub D., et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004, 64:292-297.
10. Porter M.P., Kerrigan M.C., Donato B.M.K., et al. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urol Oncol 2011, 29:252-258.
11. Carreca I., Balducci L. Cancer chemotherapy in the older cancer patient. Urol Oncol 2009, 27:633-642.
12. Raj G.V., Karavadia S., Schlomer B., et al. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. Cancer 2011, 117:276-282.
13. Chamie K., Hu B., DeVere White R.W., et al. Cystectomy in the elderly: Does the survival benefit in younger patients translate to the octogenarians?. BJU Int 2008, 102:284-290.
14. Donat S.M., Siegrist T., Cronin A., et al. Radical cystectomy in octogenarians-does morbidity outweigh the potential survival benefits?. J Urol 2010, 183:2171-2177.
15. Fairey A., Chetner M., Metcalfe J., et al. Associations among age, comorbidity and clinical outcomes after radical cystectomy: Results from the Alberta Urology Institute radical cystectomy database. J Urol 2008, 180:128-134. Discussion 134.
16. Liberman D., Lughezzani G., Sun M., et al. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology 2011, 77:660-666.
17. Konety B.R., Dhawan V., Allareddy V., et al. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: Data from the health care utilization project. JURO 2005, 173:1695-1700.
18. Koppie T.M., Serio A.M., Vickers A.J., et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008, 112:2384-2392.
19. Stimson C.J., Chang S.S., Barocas D.A., et al. Early and late perioperative outcomes following radical cystectomy: 90-Day readmissions, morbidity, and mortality in a contemporary series. J Urol 2010, 184:1296-1300.
20. Chang S.S., Alberts G., Cookson M.S., et al. Radical cystectomy is safe in elderly patients at high risk. JURO 2001, 166:938-941.
21. Farnham S.B., Cookson M.S., Alberts G., et al. Benefit of radical cystectomy in the elderly patient with significant co-morbidities. Urol Oncol 2004, 22:178-181.
22. Morgan T.M., Keegan K.A., Barocas D.A., et al. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol 2011, 186:829-834.
23. Aghazadeh M.A., Barocas D.A., Salem S., et al. Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort. J Urol 2011, 185:85-89.
24. Tran E., Souhami L., Tanguay S., et al. Bladder conservation treatment in the elderly population: Results and prognostic factors of muscle-invasive bladder cancer. Am J Clin Oncol 2009, 32:333-337.
25. Montie J.E. Against bladder sparing: surgery. JURO 1999, 162:452-455. Discussion 455-7.